Report questions FDA approval of controversial anticoagulant
McCarthy, M.
Bmj 351: H5557
2015
ISSN/ISBN: 0959-8138 PMID: 26481822 Document Number: 683239
Document emailed within 1 workday
Related Documents
Sivolap, I.P. 2007: To some controversial questions of the course and prognosis of alcoholism Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova Suppl. 1: 79-83Zemskov, M.V.; Zhuravleva, N.V.; Zemskov, V.M. 1973: Controversial questions concerning immunology and infectious diseases Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 50(6): 8-14
Rokhlin, L.L. 1979: Certain controversial questions in our understanding of borderline states Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 79(11): 1595-1598
Marwick, C. 1983: FDA committee questions Fluosol efficacy; US approval not imminent JAMA 250(19): 2585-2586
Meshkov, A.P. 1987: Controversial questions relating to the concept and nomenclature of functional cardiovascular pathology Sovetskaia Meditsina 1987(1): 33-36
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19
Grant, D.J. 2001: More on BMA's approval of acupuncture. BMA report is not wrong Bmj 322(7277): 45-46
Barber, K.; Freed, N.; Proebstle, P.; Biondi, R. 1983: The lupus anticoagulant: report of a case Journal of the American Osteopathic Association 82(9): 669-673
de Hoyos López, M.C.; Pascual Pérez, J.M.; Blanco Quirós, A.; Guerola Delgado, D.; Valbuena Crespo, C.; Alvarez Guisasola, F.J. 1999: Lupus anticoagulant in children. Report of 4 cases Anales Espanoles de Pediatria 51(6): 637-642
Byshevskiĭ, A.S.; Sokolovskiĭ, S.R. 1982: Potentiation of the anticoagulant effects of a phosphatidylserine-containing anticoagulant and heparin Voprosy Meditsinskoi Khimii 28(2): 30-34
Kueh, Y.K.; Ee, B.K.; Teoh, P.C. 1982: Resistance to oral anticoagulant therapy - case report and review of literature Singapore Medical Journal 23(2): 114-115
Wilson, J.J.; Zahn, C.A.; Ross, S.D.; Newman, H. 1986: Association of embolic stroke in pregnancy with the lupus anticoagulant. A case report Journal of Reproductive Medicine 31(8): 725-728
Chaiteerakij, R.; Treeprasertsuk, S.; Mahachai, V.; Kullavanijaya, P. 2008: Anticoagulant-induced intramural intestinal hematoma: report of three cases and literature review Journal of the Medical Association of Thailand 91(8): 1285-1290
Marutaka, M.; Kubota, Y.; Yoshida, R.; Orita, Y. 2009: Difficult management of warfarin anticoagulant therapy due to S-1 administration for gastric cancer--report of a case Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1561-1563
Shalgian, C. 2000: IOM report on medical errors leads to questions about the NPDB Bulletin of the American College of Surgeons 85(9): 8-10
Simpson, M.A. 1989: Health care cost containment--questions and answers (or more questions?) West Virginia Medical Journal 85(6): 240-247
Miale, J.B. 1979: Prothrombin time standardization report of the expert panel on oral anticoagulant control: a minority opinion Thrombosis and Haemostasis 42(4): 1132-1134
Vivaldi, P.; Rossetti, G.; Galli, M.; Finazzi, G. 1997: Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature Haematologica 82(3): 345-347
Alberty-Ryöppy, A.; Juntunen, J.; Salmi, T. 1985: Femoral neuropathy following anticoagulant therapy for "economy class syndrome" in a young woman. A case report Acta Chirurgica Scandinavica 151(7): 643-645
Takaki, A.; Ogawa, H.; Wakeyama, T.; Iwami, T.; Kimura, M.; Tanaka, T.; Uchinoumi, H.; Matsuzaki, M. 2004: Ampulla cardiomyopathy with left ventricular apical mural thrombi resolved by anticoagulant therapy without systemic complication: a case report Journal of Cardiology 44(6): 243-250